Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Avoid going under the knife, relief is here for varicose vein sufferers


News provided by

Delivra Inc.

Oct 09, 2013, 12:00 ET

Share this article

Share toX

Share this article

Share toX

Research shows natural botanicals improve circulation and promote venous health, experts advise

TORONTO, Oct. 9, 2013 /CNW/ - Active healing ingredients found in nature are effective in the treatment of early stage venous disease such as varicose veins, reports the Natural Actives Health and Wellness Advisory Board*, a panel of Canadian academics and health practitioners.

A report from the Advisory Board entitled Varicose Vein Research Review: Relevant research findings and advice to Canadians regarding natural treatment options, concludes that the current body of research suggests that treatment with natural botanical ingredients Hamamelis Virginianis (witch hazel), Aesculus Hippocastanum (horse chestnut) and Rutin, can contribute to strengthened veins, increased circulation and promoted venous health over time.

Harnessing the power of these and other healing natural botanicals, LivRelief™ Varicose Vein Cream is uniquely formulated to target the painful symptoms and unsightly complications associated with varicose veins - and it may help reduce the number of patients in Canada who seek treatment by going under the knife.

"We know that tannins and oils in witch hazel act as natural vasoconstrictors, aescin found in horse chestnut seed blocks leakage and strengthens capillary walls and rutin contains an antioxidant called quercetin that is effective in reducing inflammation," says pharmacist and certified menopause practitioner Carolyn Whiskin. Whiskin is a member of the Natural Actives Health and Wellness Advisory Board. "The research shows that all of these actives have demonstrated properties which can improve vein health, by strengthening the walls of veins, allowing for greater blood flow and therefore reducing the fluid leakage and blood pooling that causes varicose veins."

Until now, there have always been challenges in the stabilization of these compounds to ensure effective topical delivery to impacted varicose vein areas. But, LivRelief™ Varicose stands miles apart from any other products in its category due to its unique drug delivery system, delivra™.

"Our proprietary transdermal transport system actually mimics the skin's natural structure," says Dr. Joseph Gabriele, President and Chief Scientific Officer, Delivra Inc., makers of LivRelief™ products. "It allows the active healing ingredients within these natural botanicals to safely and effectively penetrate deep into the skin to directly target swollen, twisted and painful varicose veins within the body."

The delivra™ base in LivRelief™ Varicose is almost 700 per cent more effective in penetrating deep through the skin  - no other topical varicose cream in the world can provide such relief deep within the body.1 It also has an absorption rate that is six times stronger than competing topical base delivery systems.2

"Studies published in credible, international scientific journals indicate that botanical extracts can provide protective measures against venous disease," says dermatologist Dr. Sandra Skotnicki, Medical Director at The Bay Dermatology Centre and member of the Natural Actives Health and Wellness Advisory Board. "This is welcome news for Canadians who want to consider their options beyond compression stockings or prior to laser treatment or surgery.

The Natural Actives Health and Wellness Advisory Board reviewed and considered the body of evidence in this area.  Members developed research summaries and appropriate advice on how Canadians might incorporate key learnings into their health and wellness choices when it comes to improved venous health and varicose vein prevention and treatment.  The Board's report, Varicose Vein Research Review: Relevant research findings and advice to Canadians regarding natural treatment options, summarizes and presents its conclusions.

Summary of Conclusions and Advice to Canadians:

  • For many Canadians, twisted, discoloured and protruding varicose veins are unavoidable. While extremely unsightly, and often uncomfortable, varicose veins, or the less severe spider veins, are usually a cosmetic concern.  In some cases, where there are ulcers or swelling and itching or severe pain, a physician or other health professional should be consulted.

  • Lifestyle changes, such as increasing exercise and controlling weight, may have an impact for some sufferers.  Compressions stockings show effectiveness but are often not utilized, as they can be considered unattractive, uncomfortable and difficult to manage. Medical options, sometimes involving surgery, can be invasive and often prohibitively expensive.

  • A topical cream, such as LivRelief Varicose Vein Cream with delivra, brings key herbal ingredients into contact with impacted areas which can minimize the look of varicose and spider veins, while alleviating inflammation and pain. Prior to considering an invasive procedure for the treatment of varicose veins, a trial of a topical cream, such as LivRelief Varicose is suggested as a reasonable and safe option.

  • We live in a society where unavoidably long commutes by car, plane and train place unprecedented strain on our veins. We need to employ safe, natural and effective solutions that can be used to prevent and manage varicose veins at early stages before they become a problem. For many, the solution may be as easy as applying a topical cream, like LivRelief Varicose Vein Cream and wearing compression socks rated 15-20 mmHg.

The use of a natural topical powered by a highly efficacious transdermal delivery system, such as LivRelief™ Varicose can help reduce the risk of vascular disease, though it is one of several factors in preventing disease. People seeking to reduce their risk of vascular and other disease should always maintain a healthy body weight, enjoy regular physical activity, avoid smoking, and choose lower-fat food products.

LivRelief™ Varicose Vein Cream is now available in the analgesics section at select drugstores, health food stores and grocery stores across Canada.  The suggested retail price for a 50g bottle is $34.99.  The product can also be purchased directly at www.livrelief.com.

About Delivra Inc.
Headquartered in Burlington, Ontario, Canada, Delivra Inc. is comprised of a team of innovators who bring together a collective 125 years of medical and corporate experience. The goal of the company is to develop natural, safe and effective medications, using the revolutionary new delivery system, delivra™. Consumers requiring further information on the various LivRelief™ products or the results of clinical trials can visit www.livrelief.com.

*The Natural Health and Wellness Advisory Board is supported by an unconditional education grant from Delivra Inc., the makers of delivra™, LivRelief™ and LivSport™ in Canada.

1 Based on results of a clinical trial of Delivra™ conducted by Delivra Inc.

2 Based on results of a clinical trial of Delivra™ conducted by Delivra Inc.

SOURCE: Delivra Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.